News
1d
GlobalData on MSNClinical trial supply chains in the US navigate pharma tariffsThe 2025 Clinical Trial Supply West Coast conference will gather experts to discuss US trial operations in a shifting tariff ...
The Food and Drug Administration Aug. 7 announced a new program to help improve the domestic pharmaceutical supply chain by ...
The regulatory environment is placing extreme pricing pressure on pharmaceutical manufacturers. Their success in the market ...
President Trump has imposed a 15 percent tariff on most items in a trade agreement with the European Union, with ...
Australia is very concerned about U.S. President Donald Trump's latest threat to raise tariffs on pharmaceutical imports by ...
Pharma and Biopharma is a trillion-dollar industry providing ample career opportunities for laboratory scientists and entrepreneurs. Join Principal Consultant Michael W. Dong of MWD Consulting as he ...
In the high-stakes world of pharmaceutical marketing, navigating the industry's complex regulatory environment requires knowledge and precision. The slightest deviation from established standards ...
References i “Electronic Code of Federal Regulations, Title 21, Chapter 1, Subchapter A, Part 11,” U.S. Food and Drug Admin- istration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results